This month, The Spectator becomes the first magazine in history to print 10,000 issues,

and we'd like to celebrate with you.

Subscribe to The Spectator for 12 weeks for just £12.

Plus, we'll send you a bottle of commemorative Spectator gin, absolutely free.

Go to spectator.com.uk forward slash celebrate.

Hello and welcome to Coronomics, the Spectator's six-part series on stories from countries turned upside down by COVID-19.

I'm Kate Andrews. This new podcast will feature our panel, based around the world, as each person

selects a story that gives you an inside look as to what's happening outside their windows.

Sylvia Ciorilli Borelli is reporting from Rome and former Italian correspondent for Politico Europe.

Jennifer Crieri is reporting from Hong Kong and managing editor of the Hong Kong Free Press.

And Nick Gillespie is reporting from New York City and editor-at-large for Reason magazine.

Welcome all.

Nick, your story this week comes from the New York Times, a lengthy examination of the Trump administration's handling of COVID-19 in the early weeks.

Tell us about it.

Yeah, it's called he could have seen what was coming behind Trump's failure on the virus.

And it tracks using a lot of internal memos from health agencies in particular, but other people involved in the Trump

administration and the federal government, starting really in January and all of the missteps

and missed opportunities that the administration had to kind of get ahead of the virus coming

here.

And what is interesting to me is that, first off, it's a very detailed interior look into the decision-making apparatus of the Trump administration, which to be open, you know, like I don't think that any other administration would have been much different.

And this is not as much in this story, but in other stories, which the Times and other people have covered, the two main public health agencies, the CDC

Centers for Disease Control and Prevention, and the Food and Drug Administration, had early

...